Patents

A high performing novel protein marker for predicting the immunological phenotype of triple negative breast cancer (TNBC) PCT filed (10202500800Y)
Prognostic biomarkers for identification of treatment responders among CHB patients PCT filed (IP2024-198-01)
High-Risk Breast Cancer Subclass Discovery with High Performing Molecular Signatures for Clinical Stratification. Singapore Provisional application filed (10202600181V)
High Performing Proteomic Signatures for Aggressive Immune Cold Lung Cancer Singapore Provisional application filed (10202600182W)
High performing novel diagnostic urinary marker panels for early and advanced stages of Chronic Kidney Disease of uncertain etiology (CKDu) PCT filed (10202501285T)

Biomarker discovery in the urine of early-stage bladder cancer patients. Patented in USA, Europe, Japan, China & Singapore. Licensed to Biocheetah Pte Ltd. (PC/SW/2934/0518/ ETPL-IMCB)

Institute of Molecular and Cell Biology61 Biopolis Drive, #7-12/13, Proteos, Singapore 138673

Page updated

Google Sites

Report abuse